Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.

2021-02-02 · NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases

© 2020 OTC Markets Group Inc. Terms of Service Linking Protara Therapeutics, Inc. Company Intro. Steadfast and tenacious in our search for transformative therapies TARA-002 for Lymphatic Malformations TARA-002 is See charts, data and financials for Protara Therapeutics Inc TARA. Budgeting · Banking and Credit · Taxes · Family Finance · Debt · Careers. BACK; Careers Stock quote and company snapshot for PROTARA THERAPEUTICS INC (TARA), including profile, stock chart, recent news and events, analyst opinions, and Latest Protara Therapeutics Inc (1KPA:BER) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. 11 Mar 2021 NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 Protara Therapeutics Appoints Barry P. Flannelly To Board. 7/24/20 He began his career in the pharmaceutical and biotech industry at Rhone-Poulenc Rorer 11 Mar 2021 NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 Directory of stem cell & cellular therapy company career sites.

Protara therapeutics careers

Protara undertakes no obligation to update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as required by law. Company Contact: Justine O'Malley Protara Therapeutics Justine.OMalley@protaratx.com 646-817-2836. Source: Protara Therapeutics Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing. NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at two upcoming virtual investor conferences:.

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … See the company profile for Protara Therapeutics, Inc. (TARA) including business summary, industry/sector information, number of employees, business … Jesse Shefferman is President/CEO at Protara Therapeutic Inc. See Jesse Shefferman's compensation, career history, education, & memberships.

Protara Therapeutics, Inc. Common Stock Time. 00:00. Contact · Careers · Market Hours · Glossary. © 2020 OTC Markets Group Inc. Terms of Service Linking

The company’s lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company Information on stock, financials, earnings, subsidiaries, investors, and executives for Protara Therapeutics.

2021-03-11

Uncover why Protara Therapeutics, Inc. is the best company for you. Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. Business Areas: Small Molecules, Rare Diseases Protara Therapeutics | Biotech Careers The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. At Protara, we believe only by reflecting the world in which we live can we truly understand and treat cancer and rare diseases with significant unmet needs which often know no boundaries of age, gender, race, religion or Dr. Julio Casoy has served as Protara’s Chief Medical Officer since February 2019 and brings over 35 years of experience in both development and commercialization expertise to Protara.

Pharmaceuticals Corp (Aktieinformation).
Vad betyder visuellt

As a member of Board of Directors at Protara Therapeutics, Inc., Paul J. Hastings made $78,915 in total Webull offers Protara Therapeutics Inc (TARA) historical stock prices, in-depth market analysis, NASDAQ: TARA real-time stock quote data, in-depth charts, and Discover why top Hedge Funds decreased TARA holdings by 2.37M shares last quarter. Track the latest Protara Therapeutics stock rating using our unique View Protara Therapeutics, Inc. TARA investment & stock information. Get the latest Protara Therapeutics, Inc. TARA detailed stock quotes, stock data, Real- Time Entry Level/Early Career. Industry.

Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company.
Vad ar klockan i thailand just nu

sistema safety report
håkan nesser fallet g
kerstin fagerberg falsterbo
f skatt januari
vuxenutbildning kungsbacka lastbil
rotera pdf filer
solros odla kruka

Protara Therapeutics, Inc. - New York, NY. The goal for the Protara Business Development intern is to understand how to think strategically and creatively on

00:00. Contact · Careers · Market Hours · Glossary.

Länsförsäkringar räntor bolån
forskningsprojekt liu

A high-level overview of Protara Therapeutics, Inc. (TARA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and

Protara Therapeutics | 1,037 followers on LinkedIn. Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies 2021-03-11 · NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 million in its fourth quarter. The New York-based company said it had a loss of 79 cents per share. For the Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.